The aim of the present study was to provide an integrated characterization of AP-2δ/<i>TFAP2D</i> in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). The gene discussed is TFAP2D; the disease is lung adenocarcinoma.